Fresenius Medical Care AG & Co. KGaA (ADR)
General ticker "FMS" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $14.9B (TTM average)
Fresenius Medical Care AG & Co. KGaA (ADR) does not follow the US Stock Market performance with the rate: -4.0%.
Estimated limits based on current volatility of 1.4%: low 22.75$, high 23.39$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-23, amount 0.79$ (Y3.43%)
- Total employees count: 47521 as of 2005
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [21.28$, 30.47$]
- 2026-12-31 to 2027-12-31 estimated range: [23.31$, 33.02$]
Financial Metrics affecting the FMS estimates:
- Positive: with PPE of 9.8 at the end of fiscal year the price was neutral
- Positive: Operating cash flow per share per price, % of 21.81 > 12.96
- Positive: 7.67 < Operating profit margin, % of 9.31
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.70
- Positive: -9.07 < Industry operating profit margin (median), % of 0.88
- Negative: Investing cash flow per share per price, % of -5.64 <= -4.43
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of 5.67 <= 10.29
Short-term FMS quotes
Long-term FMS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €19,453.62MM | €19,335.91MM | €19,628.00MM |
| Operating Expenses | €18,084.18MM | €17,943.51MM | €17,801.00MM |
| Operating Income | €1,369.44MM | €1,392.39MM | €1,827.00MM |
| Non-Operating Income | €-336.42MM | €-335.47MM | €-315.00MM |
| Interest Expense | €424.64MM | €407.04MM | €0.00MM |
| R&D Expense | €231.97MM | €183.49MM | €158.00MM |
| Income(Loss) | €1,033.02MM | €1,056.93MM | €1,512.00MM |
| Taxes | €300.56MM | €316.06MM | €321.00MM |
| Profit(Loss)* | €499.00MM | €537.91MM | €978.00MM |
| Stockholders Equity | €13,620.26MM | €14,576.56MM | €14,283.00MM |
| Inventory | €2,179.18MM | €2,067.92MM | €2,141.00MM |
| Assets | €33,929.81MM | €33,566.58MM | €31,002.00MM |
| Operating Cash Flow | €2,628.80MM | €2,386.14MM | €2,575.19MM |
| Capital expenditure | €684.60MM | €699.36MM | €879.24MM |
| Investing Cash Flow | €-544.23MM | €-84.94MM | €-666.18MM |
| Financing Cash Flow | €-1,858.53MM | €-2,569.30MM | €-1,375.66MM |
| Earnings Per Share** | €0.85 | €0.91 | €1.68 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.